Health Brief: Neuralink hires K Street firm; PhRMA sees executive departure
By
Megan R. Wilson
A bagel you'd recommend to a friend without hedging.
Summary
This Health Brief snippet from WP IntelligencePlus mentions that Neuralink has hired a K Street lobbying firm, and that PhRMA has lost another C-suite executive amid a leadership shuffle. It also references an experimental cancer drug that received a standing ovation. The content is very brief and appears to be a newsletter teaser or brief with minimal substantive detail.
Key quotes
· 2 pulledHealth Brief from WP IntelligencePlus: PhRMA loses another C-suite executive amid leadership shuffle
Plus: More about the experimental cancer drug that garnered a standing ovation
You might also wanna read
FDA Drug Regulator Accused of Targeting Former Business Associate's Pharmaceutical Company
The article discusses a scandal at the FDA involving a top drug regulator who allegedly used his position to target a former business associ
arstechnica.com·7mo agoThreat in Your Medicine Cabinet: The FDA's Gamble on America's Drugs
Senators Investigate Pharmaceutical Companies' Direct-to-Consumer Telehealth Platforms for Steering Patients to High-Cost Drugs
U.S. senators are investigating direct-to-consumer (DTC) telehealth platforms operated by pharmaceutical companies like Eli Lilly and Pfizer
arstechnica.com·4mo ago
Research Reveals Persistent Drug Pricing Distortions from PBM-Owned Pharmaceutical Companies
The article examines the persistent distortions in U.S. drug pricing, particularly focusing on vertically integrated pharmacy benefit manage
46brooklyn.com·7mo ago
Tech Companies Stock Offices with Nicotine Products to Boost Employee Productivity
Tech companies like Palantir and Hello Patient are stocking office vending machines with nicotine products (pouches from startups Lucy and S
fortune.com·12d agoTech Companies Stock Offices with Nicotine Products to Boost Employee Productivity
Tech companies like Palantir and Hello Patient are stocking office vending machines with nicotine products (pouches from startups Lucy and S
fortune.com·12d ago
Harvard Public Health Dean Paid $150,000 as Expert Witness Against Tylenol Before Publishing Autism Research Used by Trump Administration
Harvard School of Public Health Dean Andrea A. Baccarelli received at least $150,000 to testify as an expert witness against Tylenol's manuf
thecrimson.com·8mo ago